UNSPSC 42142530: Diagnostic procedure needles

In this classification, this commodity indicates a product that is a hollow needle commonly used for rapid delivery or evacuation of liquids in diagnostic procedure in a medical setting. US FDA regulates Diagnostic procedure needles under 21 CFR 880.5440 and under FDA product code FPA. Most nations, for tariff and trade purposes, schedule these products under HS 901832.

UNSPSC 42142530 Diagnostic procedure needles is a Commodity code that encompasses specimen collection supplies, including phlebotomy needles and related collection equipment used in laboratory and clinical settings by state and local health agencies, correctional facilities, and cooperative purchasing alliances. State and local government procurement under this code reflects broader medical supply and laboratory services contracting where diagnostic needles are bundled with specimen collection, courier services, testing, and phlebotomist labor. The issuing bodies include county health departments, county correctional systems, state cooperative purchasing alliances, and public health agencies that consolidate procurement for multiple government members.

Recent activity shows the code is driven primarily by cooperative purchasing vehicles and county-level laboratory services solicitations. The Minnesota Multigovernmental Cooperative Purchasing Alliance (MMCAP), operating under the State of Minnesota Department of Administration's Office of State Procurement, issued an RFP on June 12, 2026 (due July 20, 2026) for full-line medical supplies and equipment distributors to serve approximately 8,000 government members across the United States, with specimen collection supplies and needles and syringes explicitly named in the scope. Marion County, Oregon issued an ITB on July 10, 2026 (due July 24, 2026) for laboratory testing services and phlebotomy for adults in custody, encompassing specimen collection supplies alongside testing, courier services, and phlebotomist services. Cooperative purchasing frameworks dominate recent opportunity volume, with MMCAP representing approximately $300 million in annual collective purchasing power across its medical supply portfolio. Activity is concentrated in the Upper Midwest and Pacific Northwest, with Minnesota and Oregon showing the most recent solicitation activity, though MMCAP's scope spans approximately twenty states and multiple jurisdictions nationwide.